CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Breaking barriers in cell and gene therapy: advancing ATMPs through innovation and collaboration

Breaking barriers in cell and gene therapy: advancing ATMPs through innovation and collaboration

A Ussi, A Andreu, F Bietrix et al
28 February 2025
Foreword
 Connecting innovations to great gains for the ultimate stakeholder: the patient

Connecting innovations to great gains for the ultimate stakeholder: the patient

Michelle Berg
13 January 2025
Foreword
 Cellular immunotherapy: beyond hemalignancies

Cellular immunotherapy: beyond hemalignancies

Nina Bauer
09 September 2024
Foreword
 Viral and non-viral vector platform evolution

Viral and non-viral vector platform evolution

Zhenghong Gao
19 June 2024
Foreword
 The March 2024 issue of Cell & Gene Therapy Insights

The March 2024 issue of Cell & Gene Therapy Insights

Shon Green
02 April 2024
Foreword
 Gene delivery platform evolution part 2: non-viral—Foreword

Gene delivery platform evolution part 2: non-viral—Foreword

Lynn Zechiedrich
05 August 2023
Foreword
 Gene therapy CMC and analytics—Foreword

Gene therapy CMC and analytics—Foreword

Lauren Drouin
03 August 2023
Foreword
 Viral gene delivery platform evolution

Viral gene delivery platform evolution

Aravind Asokan
29 June 2023
Foreword
 Spotlight on modality & platform development trends

Spotlight on modality & platform development trends

David Dilillo
02 May 2023
Foreword
 Spotlight on combination therapy development: strategic directions towards improving current I-O response rates

Spotlight on combination therapy development: strategic directions towards improving current I-O response rates

Adil Daud, Alexandra Haugh, Saya Jacob
06 June 2022
Foreword
 Gene delivery & gene editing platform evolution

Gene delivery & gene editing platform evolution

Louise Rodino-Klapac
20 May 2022
Foreword
 Vector bioprocessing spotlight

Vector bioprocessing spotlight

Franz Gerner
02 May 2022
Foreword
 Raw & starting materials for cell and gene therapies

Raw & starting materials for cell and gene therapies

Gary du Moulin
11 March 2022
Foreword
 Gene therapy CMC and quality control

Gene therapy CMC and quality control

Christine Le Bec
21 October 2021
Foreword
 Scale-up and scale-out: what do we really need and how will we get there?

Scale-up and scale-out: what do we really need and how will we get there?

Jan Thirkettle
15 October 2021
Foreword
 Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?

Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?

Christian Schmees
04 August 2021
Foreword
 Cell therapy CMC and quality control

Cell therapy CMC and quality control

Christiane Niederlaender
13 May 2021
Foreword
 Modelling the I-O manufacturing facilities of tomorrow

Modelling the I-O manufacturing facilities of tomorrow

23 April 2021
Foreword
 Raw and starting materials

Raw and starting materials

Elizabeth Read
26 March 2021
Foreword
 Preclinical/translational tools & strategies

Preclinical/translational tools & strategies

Bruce A Bunnell
24 February 2021
Foreword
 Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

John Paul Tomtishen III
01 December 2020
Foreword